| |||
 | |||
 |
Evening Primrose | ||
|
Kava Kava | ||
|
Milk Thistle | ||
| |||
|
| Pronunciation |
 (me
PER i deen & proe METH a
zeen) |
 |
| U.S. Brand Names |
| Mepergan® |
|
| Generic Available |
|
No |
|
| Synonyms |
| Promethazine and Meperidine |
|
| Pharmacological Index |
|
Analgesic, Combination (Narcotic) |
|
| Use |
|
Management of moderate to severe pain |
|
| Pregnancy Risk Factor |
|
B/D (if used for prolonged periods or in high doses at term) |
|
| Usual Dosage |
|
Adults: I.M.: Inject 1-2 mL every 3-4 hours |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
1% to 10% of patients experience dry mouth |
|
| Patient Information |
|
See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Do not breast-feed. |
|
| Nursing Implications |
|
Monitor for CNS depression, seizures, respiratory depression, constipation, urine retention; assist with ambulation |
|
| Dosage Forms |
|
Capsule: Meperidine hydrochloride 50 mg and promethazine hydrochloride 25 mg Injection: Meperidine hydrochloride 25 mg and promethazine hydrochloride 25 per mL (2 mL, 10 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
